Bortezomib-induced reversible posterior leucoencephalopathy syndrome.
Kelly
Kevin
K
Department of Haematology, Beaumont Hospital, Dublin, Ireland. kevrkelly77@hotmail.com
Kalachand
Roshni
R
Murphy
Philip
P
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000175:diagnosis; D011719:Pyrazines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib